Decision letter for "Design, Synthesis and Biological Assessment of Erlotinib-1,2,3-Triazole Derivatives for Anticancer Applications"
Fields of Study & Subjects
Heterocyclic Compound Synthesis and Bioactivity
Synthesis and Characterization of Heterocyclic Compounds
Click Chemistry and Applications
Publication details
- Journal / source
- Publons reviews and discussion
- Publication date
- 24 January 2026
- Language
- EN